Case study

Introducing 5-dose Measles-Rubella Vaccine Vials in Zambia: Research Findings

This executive summary details the key findings from the 5-dose MCV research in Zambia: improved coverage, reduced wastage, no cold chain constraints, and healthcare workers were more willing to open a 5-dose vial.

Languages

  • English

Publication year

2019

Type

Case study

Categories

  • Vaccines & delivery devices

Diseases

  • Measles
  • Rubella

Countries

  • Zambia

Organisations

  • JSI Research & Training Institute, Inc.

Tags

  • Coverage monitoring
  • Delivery device
  • Planning, budgeting and financing
  • Refrigerator / freezer
  • Wastage

WHO Regions

  • African Region

DPCP-CASE-STUDIES

This resource appears in the following Hot Topic page:

The resource is included in the following table:

TitleAuthorYearTypeLanguage
Implementing 5-dose Measles-Rubella Vaccine Vials in Zambia Research FindingsDose Per Container Partnership (DPCP), JSI2020ReportEnglish
Introducing 5-dose Measles-Rubella Vaccine Vials in Zambia: Research FindingsDose Per Container Partnership (DPCP), JSI2019Case studyEnglish
The Effects of Dose Per Container Change in ZambiaDose Per Container Partnership (DPCP), JSI2019Case studyEnglish
Vietnam: Effects of Changing Dose per Container on the Immunization SystemDose Per Container Partnership (DPCP), JSI2018Case studyEnglish
Vaccination in Zambia - Healthworker Experiences Using 5-dose MR VaccineDose Per Container Partnership (DPCP), JSI2018Case studyEnglish
Senegal: Weighing the Costs and Benefits of Changing DPCDose Per Container Partnership (DPCP), JSI2018Case studyEnglish
Modeling to Support Decision-Making for 5-dose Measles-Rubella Routine Vaccination in ZambiaDose Per Container Partnership (DPCP), JSI2018Case studyEnglish
Measles Vaccination in Zambia: Balancing Coverage & WastageDose Per Container Partnership (DPCP), JSI2018Case studyEnglish
Information Gaps in Decision-Making on Vaccine Presentation in 3 Francophone CountriesDose Per Container Partnership (DPCP), JSI2017Case studyEnglish
Ghana: Understanding Changes in Vaccine PresentationDose Per Container Partnership (DPCP), JSI2018Case studyEnglish

PORTFOLIO-LESSONS

This resource appears in the following Hot Topic page:

The resource is included in the following table:

TitleAuthorYearTypeLanguage
The switch from ROTARIX to ROTAVAC in Ghana: Answers to four key questionsPATH2022ReportEnglish
The Health Benefits of Rotavirus Immunization for Children in Palestine: Results of a Vaccine Impact AnalysisPATH, Rostropovich-Vishnevskaya Foundation, Palestine Ministry of Health2021ReportRussian
Economic Implications of Switching Rotavirus Vaccine Products in Palestine's Immunization ProgramPATH2020Case studyArabic, English, Russian, French
Introducing 5-dose Measles-Rubella Vaccine Vials in Zambia: Research FindingsDose Per Container Partnership (DPCP), JSI2019Case studyEnglish
The effects of switching from 10 to 5-dose vials of MR vaccine on vaccination coverage and wastage: A mixed-method study in ZambiaKirstin Krudwig, Barbara Knittel, Ali Karim, Natasha Kanagat, Wendy Prosser, Guissimon Phiri, Frances Mwansa, Robert Steinglass2020Journal articleEnglish
A Switch for Sustainability in Ghana's Rotavirus Vaccine ProgramGeorge Armah2020Case studyEnglish
The Operational Impact of Switching from a Two-Dose to a One-Dose HPV Vaccination Schedule: Lessons Learned from Burkina Faso, Ethiopia, and Solomon Islands HAPPI2025ReportEnglish
Economic implications of switching to the hexavalent infant vaccine in an immunization program in IndiaPawan Kumar, Kapil Singh, Arindam Ray, Arup Deb Roy, Susmita Chatterjee, Homero Hernandez, Amrita Kumari2026Journal articleEnglish

Added by: Wendy Prosser

Added on: 2020-03-13 04:10:57

Hits: 3056

Links

Uploaded file

DPCPZAMBIAExecutiveSummary_final.pdf

Click to Download